Xin Yu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Xin Yu has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Chunyan Yang
School of Architecture, Southwest Jiaotong University, Chengdu 611756, China
1 shared publication - Dan Huang
Department of Preventive Medicine, Seoul National University College of Medicine, Seoul 03080, Korea
1 shared publication - Fang Zeng
Acupuncture and Tuina School, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China
1 shared publication - Fanrong Liang
Acupuncture and Tuina School, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China
1 shared publication - Fengyuan Huang
Acupuncture and Tuina School/The 3rd Teaching Hospital, Chengdu University of Traditional Chinese Medicine, Chengdu, People’s Republic of China
1 shared publication - Guixing Xu
Department of Acupuncture-Moxibustion and Rehabilitation, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, People’s Republic of China
1 shared publication
Latest Publications
- 10 April 2025
- Published by Wiley in Applied Psychology: Health and Well-Being
- Vol. 17 (2) , e70025
The more resilient students are, the sooner they recover from examination stress: A daily diary study
Resilience, particularly under stressful circumstances, is essential for well‐being. Prior research has shown the positive effects of resilience on overall self‐esteem and emotional balance, but the dynamic nature of these attributes has consistently been overlooked. This study investigated how resilience influences state self‐esteem and emotional balance during periods of examination stress. To this end, we utilized a 13‐day daily diary design to collect data once a day from 212 participants (160 females; Mage = 18.30; SDage = 1.03). A multilevel linear model was constructed using Hierarchical Linear Modeling (HLM) to examine the effects of resilience on state self‐esteem and emotional balance during daily stressful situations. Our findings revealed that resilience predicted higher levels of both state self‐esteem and emotional balance, confirming previous studies. Notably, students with higher resilience demonstrated quicker recovery in these areas, underscoring resilience's role in sustaining well‐being. This study contributes to the expanding literature on resilience by highlighting its value in maintaining self‐esteem and emotional stability.
- 10 April 2025
- Published by Wiley in Applied Psychology: Health and Well-Being
- Vol. 17 (2) , e70025
The more resilient students are, the sooner they recover from examination stress: A daily diary study
Resilience, particularly under stressful circumstances, is essential for well‐being. Prior research has shown the positive effects of resilience on overall self‐esteem and emotional balance, but the dynamic nature of these attributes has consistently been overlooked. This study investigated how resilience influences state self‐esteem and emotional balance during periods of examination stress. To this end, we utilized a 13‐day daily diary design to collect data once a day from 212 participants (160 females; Mage = 18.30; SDage = 1.03). A multilevel linear model was constructed using Hierarchical Linear Modeling (HLM) to examine the effects of resilience on state self‐esteem and emotional balance during daily stressful situations. Our findings revealed that resilience predicted higher levels of both state self‐esteem and emotional balance, confirming previous studies. Notably, students with higher resilience demonstrated quicker recovery in these areas, underscoring resilience's role in sustaining well‐being. This study contributes to the expanding literature on resilience by highlighting its value in maintaining self‐esteem and emotional stability.
- Open Access
- 2 October 2023
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 11, 1235672
Acupuncture as adjunctive therapy for patients with AECOPD: study protocol for a multicenter, randomized controlled trial
Background: The acute exacerbation of chronic obstructive pulmonary disease (AECOPD) is a common respiratory disease among older adults, which imposes a significant burden on individuals and society and poses a major challenge to the global public health system due to its high morbidity and mortality. Acupuncture is effective for AECOPD, but its efficacy has been questioned due to the limited methodological quality. Thus, we aim to investigate the efficacy of acupuncture as adjunctive therapy for AECOPD and determine whether the efficacy of acupuncture differs with the type of acupoint combinations.Methods and analysis: This study proposes a prospective, multicenter randomized controlled trial that will comprise four groups, including two acupuncture treatment groups, one sham acupuncture group, and one basic treatment group. The acupuncture treatment groups will be distinguished by their focus on different patterns of acupoint combination, namely the Xi-cleft and He-sea acupoint combination and the Eight Confluence points acupoint combination, which may vary in clinical efficacy based on traditional acupuncture theories. The study aims to randomize 556 patients in a 1:1:1:1 ratio across the four groups. Each patient in acupuncture group or sham acupuncture group will receive routine drug therapy and 7 sessions of acupuncture treatment over 1 week. Participants in the basic treatment group will only receive routine drug therapy. The trial will be conducted in seven hospitals located in China. The primary outcomes in this trial will include differences in the Breathlessness, Cough, and Sputum Scale (BCSS) before randomization, 7 days after randomization, 5 and 9 weeks after randomization.Ethics and dissemination: Ethical approval was obtained from the Sichuan Regional Ethics Review of Committee on Traditional Chinese Medicine (Approval ID: 2022KL-068). The results of this study will be distributed through peer-reviewed journals.Clinical Trial Registration: ClinicalTrials.gov, identifier ChiCTR2200064484.
- 2 October 2023
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 11, 1235672
Open AccessAcupuncture as adjunctive therapy for patients with AECOPD: study protocol for a multicenter, randomized controlled trial
Background: The acute exacerbation of chronic obstructive pulmonary disease (AECOPD) is a common respiratory disease among older adults, which imposes a significant burden on individuals and society and poses a major challenge to the global public health system due to its high morbidity and mortality. Acupuncture is effective for AECOPD, but its efficacy has been questioned due to the limited methodological quality. Thus, we aim to investigate the efficacy of acupuncture as adjunctive therapy for AECOPD and determine whether the efficacy of acupuncture differs with the type of acupoint combinations.Methods and analysis: This study proposes a prospective, multicenter randomized controlled trial that will comprise four groups, including two acupuncture treatment groups, one sham acupuncture group, and one basic treatment group. The acupuncture treatment groups will be distinguished by their focus on different patterns of acupoint combination, namely the Xi-cleft and He-sea acupoint combination and the Eight Confluence points acupoint combination, which may vary in clinical efficacy based on traditional acupuncture theories. The study aims to randomize 556 patients in a 1:1:1:1 ratio across the four groups. Each patient in acupuncture group or sham acupuncture group will receive routine drug therapy and 7 sessions of acupuncture treatment over 1 week. Participants in the basic treatment group will only receive routine drug therapy. The trial will be conducted in seven hospitals located in China. The primary outcomes in this trial will include differences in the Breathlessness, Cough, and Sputum Scale (BCSS) before randomization, 7 days after randomization, 5 and 9 weeks after randomization.Ethics and dissemination: Ethical approval was obtained from the Sichuan Regional Ethics Review of Committee on Traditional Chinese Medicine (Approval ID: 2022KL-068). The results of this study will be distributed through peer-reviewed journals.Clinical Trial Registration: ClinicalTrials.gov, identifier ChiCTR2200064484.